Madame Emilie CLAY / PhD

Contact details

Professional experience

Field of activity : Economie de la santé

Contract type : Entreprises

Function : Lead analyst

Organization or company : Conseils en économie de la santé et accès au marché

Company size : 50-99

City : PAris

Country : FRANCE

Jobs

Research : NON

Skills

Travail en équipe, autonomie et initiative.

Techniques

Logiciels de statistique: SAS, SPAD, R, Scilab. Programmation: C, C++, Scheme, Pascal, Visual Basic, SQL. Bureautique: Word, Excel, PowerPoint, Access. Psychométrie, Econométrie, Données de Survie, Biostatistique.

PhD

Title : Biologie-Santé - Spécialité Recherche Clinique et Santé Publique

First registration date : 1 February 2011 / 7A

Doctoral school : Sciences de la Vie et de la Santé

Thesis defense date : 7 December 2016

Subject : Développement et Validation d'un indicateur complet rassemblant une évaluation clinimétrique et un indicateur de qualité de vie spécifique à la maladie d'Huntington dans six pays européens (France, Italie, Suède, Allemagne, Grande Bretagne, Espagne)

Thesis supervisor : AUQUIER Pascal

Thesis co-supervisor : TOUMI Mondher

Research unit : SPMC - Santé Publique et Maladies Chroniques : Qualité de Vie, Concepts, Usages et Limites, Déterminants

Master's degree

Title : mention mathématiques et applications spécialité statistique

September 2010 - Université Paris 6

Mention : bien

Publications

  • Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life Instrument.
    Int Clin Psychopharmacol., 2012
    Clay E, De Nicola A, Dorey J, Squitieri F, Aballéa S, Martino T, Tedroff J, Zielonka D, Auquier P, Verny C, Toumi M.
    http://www.ncbi.nlm.nih.gov/pubmed/22508443
  • Further evidence of reliability and validity of the Huntington's disease quality of life battery for carers: Italian and French translations.
    Qual Life Res., 2013
    Aubeeluck A, Dorey J, Squitieri F, Clay E, Stupple EJ, De Nicola A, Buchanan H, Martino T, Toumi M.
    http://www.ncbi.nlm.nih.gov/pubmed/22821667
  • Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic model.
    Expert Rev Pharmacoecon Outcomes Res, 2015
    Hu S, Yu X, Chen S, Clay E, Toumi M, Milea D.
    http://www.ncbi.nlm.nih.gov/pubmed/26176750
  • Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States.
    J Med Econ., 2015
    Asche CV1, Clay E, Kharitonova E, Zah V, Ruby J, Aballéa S.
    http://www.ncbi.nlm.nih.gov/pubmed/25851505
  • Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence.
    J Med Econ., 2014
    Clay E, Khemiri A, Zah V, Aballéa S, Ruby J, Asche CV.
    http://www.ncbi.nlm.nih.gov/pubmed/24841329
  • A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder.
    Value Health., 2013
    Chollet J, Saragoussi D, Clay E, François C.
    http://www.ncbi.nlm.nih.gov/pubmed/24326166
  • Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France.
    BMC Endocr Disord, 2013
    Guelfucci F, Clay E, Aballéa S, Lassalle R, Moore N, Toumi M.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653727/
  • Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.
    Eur J Clin Pharmacol., 2013
    Clay E, Falissard B, Moore N, Toumi M.
    http://link.springer.com/article/10.1007%2Fs00228-012-1424-1
  • Burden and drivers of health-related quality of life among French and Italian caregivers of Huntington's disease patients
    Rare disease journal, 2015
    Dorey J., Urbinati D., Clay E., Aubeeluck A., Squitieri F.

  • The quality of life of Spanish patients with Huntington's disease
    Rare disease journal, 2015
    Dorey J., Clay E., Belhadj A., Khemiri A., Trigo P.

  • Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.
    Human vaccine immunotherapy, 2016
    Uhart M, Bricout H, Clay E, Largeron N.
    http://www.tandfonline.com/doi/full/10.1080/21645515.2016.1180490

Languages

Anglais : C2 - Courant